{"id":70624,"date":"2025-12-29T10:30:21","date_gmt":"2025-12-29T01:30:21","guid":{"rendered":"https:\/\/www.marketresearch.co.jp\/insights\/antibody-drug-conjugates-market-mordor\/"},"modified":"2026-11-03T07:41:31","modified_gmt":"2026-11-02T22:41:31","slug":"antibody-drug-conjugates-market-mordor","status":"publish","type":"post","link":"https:\/\/www.marketresearch.co.jp\/insights\/antibody-drug-conjugates-market-mordor\/","title":{"rendered":"\u6297\u4f53\u85ac\u7269\u8907\u5408\u4f53\u5e02\u5834\uff1a\u898f\u6a21\u30fb\u30b7\u30a7\u30a2\u5206\u6790\u3001\u6210\u9577\u52d5\u5411\u3001\u4e88\u6e2c (2025\u5e74\uff5e2030\u5e74)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2025\/12\/antibody-drug-conjugates-market-1747214643261-major-players-scaled.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2025\/12\/antibody-drug-conjugates-market-size-image-1747214345800.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">\n    1. \u306f\u3058\u3081\u306b<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          1.1 \u8abf\u67fb\u306e\u524d\u63d0\u6761\u4ef6 &amp; \u5e02\u5834\u306e\u5b9a\u7fa9<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          1.2 \u8abf\u67fb\u7bc4\u56f2<\/p>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">\n    2. \u8abf\u67fb\u65b9\u6cd5<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">\n    3. \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">\n    4. \u5e02\u5834\u6982\u6cc1<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          4.1 \u5e02\u5834\u6982\u8981<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.2 \u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.2.1 \u56fa\u5f62\u816b\u760d\u306e\u767a\u751f\u7387\u306e\u5897\u52a0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.2 65\u6b73\u4ee5\u4e0a\u306e\u4eba\u53e3\u5c64\u306e\u6025\u901f\u306a\u62e1\u5927<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.3 \u7814\u7a76\u958b\u767a\u8cc7\u91d1\u306e\u52a0\u901f\u3068\u81e8\u5e8a\u8a66\u9a13\u306e\u958b\u59cb<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.4 \u88fd\u85ac\u6295\u8cc7\u306e\u5897\u52a0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.5 \u4f4e\u6bd2\u6027\u3067\u52b9\u679c\u7684\u306a\u85ac\u5264\u3078\u306e\u9700\u8981\u306e\u5897\u52a0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.6 \u65e5\u672c\u304a\u3088\u3073\u30c9\u30a4\u30c4\u306b\u304a\u3051\u308b\u5916\u6765ADC\u6295\u4e0e\u306b\u5bfe\u3059\u308b\u511f\u9084\u306e\u62e1\u5927<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.3 \u5e02\u5834\u306e\u963b\u5bb3\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.3.1 \u9ad8\u3044\u6cbb\u7642\u8cbb<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.2 \u30da\u30a4\u30ed\u30fc\u30c9\u4f9b\u7d66\u306e\u5236\u7d04\uff08\u30aa\u30fc\u30ea\u30b9\u30bf\u30c1\u30f3\/PBD\uff09\u306b\u3088\u308b\u751f\u7523\u306e\u30dc\u30c8\u30eb\u30cd\u30c3\u30af<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.3 \u65b0\u305f\u306aT\u7d30\u80de\u30a8\u30f3\u30b2\u30fc\u30b8\u30e3\u30fc\u304a\u3088\u3073\u4e8c\u91cd\u7279\u7570\u6027\u6297\u4f53\u3068\u306e\u7af6\u5408<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.4 \u9ad8\u3044\u88fd\u9020\u306e\u8907\u96d1\u3055<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.4 \u30d0\u30ea\u30e5\u30fc\u30c1\u30a7\u30fc\u30f3\u5206\u6790<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.5 \u898f\u5236\u306e\u898b\u901a\u3057<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.6 \u6280\u8853\u306e\u898b\u901a\u3057<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.7 \u30dd\u30fc\u30bf\u30fc\u306e5\u3064\u306e\u7af6\u4e89\u8981\u56e0\u5206\u6790<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.7.1 \u8cb7\u3044\u624b\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.7.2 \u4f9b\u7d66\u8005\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.7.3 \u65b0\u898f\u53c2\u5165\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.7.4 \u4ee3\u66ff\u54c1\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.7.5 \u7af6\u4e89\u306e\u6fc0\u3057\u3055<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">\n    5. \u5e02\u5834\u898f\u6a21\u3068\u6210\u9577\u4e88\u6e2c\uff08\u91d1\u984d \u2013 \u7c73\u30c9\u30eb\uff09<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          5.1 \u88fd\u54c1\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.1.1 \u30a2\u30c9\u30bb\u30c8\u30ea\u30b9 (\u30d6\u30ec\u30f3\u30c4\u30ad\u30b7\u30de\u30d6 \u30d9\u30c9\u30c1\u30f3)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.2 \u30ab\u30c9\u30b5\u30a4\u30e9 (\u30c8\u30e9\u30b9\u30c4\u30ba\u30de\u30d6 \u30a8\u30e0\u30bf\u30f3\u30b7\u30f3)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.3 \u30d1\u30c9\u30bb\u30d6 (\u30a8\u30f3\u30db\u30eb\u30c4\u30de\u30d6 \u30d9\u30c9\u30c1\u30f3)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.4 \u30dd\u30e9\u30a4\u30d3\u30fc (\u30dd\u30e9\u30c4\u30ba\u30de\u30d6 \u30d9\u30c9\u30c1\u30f3)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.5 \u30a8\u30f3\u30cf\u30fc\u30c4 (\u30c8\u30e9\u30b9\u30c4\u30ba\u30de\u30d6 \u30c7\u30eb\u30af\u30b9\u30c6\u30ab\u30f3)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.6 \u30c8\u30ed\u30c7\u30eb\u30d3\u30fc (\u30b5\u30b7\u30c4\u30ba\u30de\u30d6 \u30b4\u30d3\u30c6\u30ab\u30f3)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.7 \u30a8\u30e9\u30d2\u30a2 (\u30df\u30eb\u30d9\u30c4\u30ad\u30b7\u30de\u30d6 \u30bd\u30e9\u30d5\u30bf\u30f3\u30b7\u30f3)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.8 \u305d\u306e\u4ed6\u306e\u627f\u8a8d\u6e08\u307fADC<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.2 \u30ea\u30f3\u30ab\u30fc\u5316\u5b66\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.2.1 \u5207\u65ad\u53ef\u80fd\u306a\u30ea\u30f3\u30ab\u30fc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.2 \u5207\u65ad\u4e0d\u53ef\u80fd\u306a\u30ea\u30f3\u30ab\u30fc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.3 \u90e8\u4f4d\u7279\u7570\u7684 \/ \u6b21\u4e16\u4ee3\u7d50\u5408\u6280\u8853<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.3 \u6a19\u7684\u6297\u539f\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.3.1 HER2<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.2 CD30<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.3 TROP2<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.4 CD22<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.5 \u305d\u306e\u4ed6<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.4 \u7528\u9014 (\u9069\u5fdc\u75c7) \u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.4.1 \u4e73\u304c\u3093<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.2 \u8840\u6db2\u304c\u3093 (\u30ea\u30f3\u30d1\u816b\u3001\u767d\u8840\u75c5)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.3 \u5c3f\u8def\u4e0a\u76ae\u304c\u3093<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.4 \u80ba\u304c\u3093<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.5 \u5a66\u4eba\u79d1\u304c\u3093 (\u5375\u5de3\u3001\u5b50\u5bae\u5185\u819c)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.6 \u305d\u306e\u4ed6\u306e\u56fa\u5f62\u816b\u760d<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.5 \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.5.1 \u75c5\u9662<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.2 \u5c02\u9580\u304c\u3093\u30bb\u30f3\u30bf\u30fc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.3 \u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u304a\u3088\u3073\u53d7\u8a17\u7814\u7a76\u6a5f\u95a2<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.4 \u305d\u306e\u4ed6<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.6 \u5730\u57df\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.6.1 \u5317\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.1.1 \u7c73\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.1.2 \u30ab\u30ca\u30c0<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.1.3 \u30e1\u30ad\u30b7\u30b3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.6.2 \u6b27\u5dde<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.2.1 \u30c9\u30a4\u30c4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.2.2 \u82f1\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.2.3 \u30d5\u30e9\u30f3\u30b9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.2.4 \u30a4\u30bf\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.2.5 \u30b9\u30da\u30a4\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.2.6 \u305d\u306e\u4ed6\u306e\u6b27\u5dde<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.6.3 \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.3.1 \u4e2d\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.3.2 \u65e5\u672c<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.3.3 \u30a4\u30f3\u30c9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.3.4 \u97d3\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.3.5 \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.3.6 \u305d\u306e\u4ed6\u306e\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.6.4 \u4e2d\u6771<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.4.1 GCC<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.4.2 \u5357\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.4.3 \u305d\u306e\u4ed6\u306e\u4e2d\u6771<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.6.5 \u5357\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.5.1 \u30d6\u30e9\u30b8\u30eb<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.5.2 \u30a2\u30eb\u30bc\u30f3\u30c1\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.6.5.3 \u305d\u306e\u4ed6\u306e\u5357\u7c73<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">\n    6. \u7af6\u5408\u60c5\u52e2<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          6.1 \u5e02\u5834\u96c6\u4e2d\u5ea6<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          6.2 \u6226\u7565\u7684\u52d5\u5411<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          6.3 \u5e02\u5834\u30b7\u30a7\u30a2\u5206\u6790<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          6.4 \u4f01\u696d\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\uff08\u30b0\u30ed\u30fc\u30d0\u30eb\u6982\u8981\u3001\u5e02\u5834\u6982\u8981\u3001\u4e3b\u8981\u30bb\u30b0\u30e1\u30f3\u30c8\u3001\u5229\u7528\u53ef\u80fd\u306a\u8ca1\u52d9\u60c5\u5831\u3001\u6226\u7565\u60c5\u5831\u3001\u5e02\u5834\u30e9\u30f3\u30af\/\u30b7\u30a7\u30a2\u3001\u88fd\u54c1\u30fb\u30b5\u30fc\u30d3\u30b9\u3001\u6700\u8fd1\u306e\u52d5\u5411\u3092\u542b\u3080\uff09<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          6.4.1 Pfizer Inc. (Seagen Inc.)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.4.2 F. Hoffmann-La Roche Ltd<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.4.3 AstraZeneca plc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.4.4 AbbVie Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.4.5 Daiichi Sankyo Co. Ltd<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.4.6 Gilead Sciences Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.4.7 Takeda Pharmaceutical Co. Ltd<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.4.8 ADC Therapeutics SA<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">\n    7. \u5e02\u5834\u6a5f\u4f1a\u3068\u5c06\u6765\u5c55\u671b<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u6297\u4f53\u85ac\u7269\u8907\u5408\u4f53\uff08ADC\uff09\u5e02\u5834\u898f\u6a21\u3001\u30b7\u30a7\u30a2\u3001\u696d\u754c\u6210\u9577\u30ec\u30dd\u30fc\u30c82030<\/p>\n<p>\u5e02\u5834\u6982\u8981<\/p>\n<p>\u6297\u4f53\u85ac\u7269\u8907\u5408\u4f53\uff08ADC\uff09\u5e02\u5834\u306f\u30012025\u5e74\u306b\u306f156.1\u5104\u7c73\u30c9\u30eb\u3068\u8a55\u4fa1\u3055\u308c\u30012030\u5e74\u307e\u3067\u306b570.2\u5104\u7c73\u30c9\u30eb\u306b\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u304a\u308a\u3001\u4e88\u6e2c\u671f\u9593\uff082025\u5e74\uff5e2030\u5e74\uff09\u4e2d\u306b29.57%\u3068\u3044\u3046\u6025\u901f\u306a\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff09\u3092\u793a\u3059\u898b\u8fbc\u307f\u3067\u3059\u3002\u3053\u306e\u5e02\u5834\u306e\u62e1\u5927\u306f\u3001\u5f37\u529b\u306a\u7d30\u80de\u6bd2\u6027\u7269\u8cea\u3092\u60aa\u6027\u7d30\u80de\u306b\u76f4\u63a5\u9001\u9054\u3059\u308b\u3053\u3068\u3067\u5168\u8eab\u6bd2\u6027\u3092\u5236\u9650\u3059\u308b\u7cbe\u5bc6\u816b\u760d\u5b66\u3078\u306e\u660e\u78ba\u306a\u79fb\u884c\u3092\u53cd\u6620\u3057\u3066\u3044\u307e\u3059\u3002\u6295\u8cc7\u5bb6\u306fADC\u306e\u6cbb\u7642\u6307\u6570\u5411\u4e0a\u3092\u8cc7\u672c\u914d\u5206\u306e\u89e6\u5a92\u3068\u898b\u306a\u3057\u3066\u304a\u308a\u3001\u3053\u308c\u306b\u3088\u308a\u521d\u671f\u6bb5\u968e\u306e\u958b\u767a\u8cc7\u91d1\u8abf\u9054\u306b\u5fc5\u8981\u306a\u30ea\u30b9\u30af\u8a31\u5bb9\u5ea6\u304c\u4f4e\u4e0b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u75c5\u9662\u3067\u306f\u3001\u8907\u6570\u65e5\u5165\u9662\u306e\u5316\u5b66\u7642\u6cd5\u30ec\u30b8\u30e1\u30f3\u3067\u306f\u306a\u304f\u3001\u65e5\u5e30\u308a\u70b9\u6ef4\u306b\u5bfe\u5fdc\u3059\u308b\u305f\u3081\u306b\u816b\u760d\u5b66\u306e\u6cbb\u7642\u7d4c\u8def\u3092\u518d\u69cb\u7bc9\u3059\u308b\u52d5\u304d\u304c\u898b\u3089\u308c\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u5909\u66f4\u306f\u3001\u75c5\u5e8a\u5360\u6709\u671f\u9593\u3092\u77ed\u7e2e\u3057\u3001\u9593\u63a5\u7684\u306b\u75c5\u9662\u306e\u55b6\u696d\u5229\u76ca\u3092\u6539\u5584\u3059\u308b\u305f\u3081\u3001ADC\u5c0e\u5165\u306e\u9b45\u529b\u3092\u9ad8\u3081\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u81e8\u5e8a\u7684\u304a\u3088\u3073\u8ca1\u653f\u7684\u5229\u70b9\u3068\u4e26\u884c\u3057\u3066\u3001\u7af6\u4e89\u7684\u7d71\u5408\u3082\u52a0\u901f\u3057\u3066\u3044\u307e\u3059\u3002\u30d5\u30a1\u30a4\u30b6\u30fc\u306b\u3088\u308b\u30b7\u30fc\u30b2\u30f3\u793e\u306e430\u5104\u7c73\u30c9\u30eb\u306e\u8cb7\u53ce\u306f\u3001\u30ea\u30f3\u30ab\u30fc\u5316\u5b66\u3001\u5f37\u529b\u306a\u30da\u30a4\u30ed\u30fc\u30c9\u3001\u304a\u3088\u3073\u5546\u696d\u898f\u6a21\u3092\u30ab\u30d0\u30fc\u3059\u308b\u7d71\u5408\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u63d0\u4f9b\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u3001\u7b2c\u4e00\u4e09\u5171\u306f\u4e2d\u56fd\u3067\u306e\u30a8\u30f3\u30cf\u30fc\u30c4\u306e\u627f\u8a8d\u3092\u7533\u8acb\u3057\u3001\u5e02\u5834\u3067\u306e\u5b58\u5728\u611f\u3092\u5f37\u5316\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u3088\u3046\u306a\u6226\u7565\u7684\u52d5\u304d\u306f\u3001ADC\u5e02\u5834\u306b\u304a\u3051\u308b\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3068\u7af6\u4e89\u306e\u6fc0\u5316\u3092\u6d6e\u304d\u5f6b\u308a\u306b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u52d5\u5411<\/p>\n<p>ADC\u5e02\u5834\u306f\u3001\u304c\u3093\u6cbb\u7642\u306b\u304a\u3051\u308b\u6a19\u7684\u7642\u6cd5\u306e\u9700\u8981\u5897\u52a0\u3001\u7814\u7a76\u958b\u767a\u6d3b\u52d5\u306e\u6d3b\u767a\u5316\u3001\u304a\u3088\u3073\u4e3b\u8981\u4f01\u696d\u9593\u306e\u63d0\u643a\u30fb\u8cb7\u53ce\u306e\u5897\u52a0\u306b\u3088\u3063\u3066\u727d\u5f15\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u7279\u306b\u3001\u4e73\u304c\u3093\u3001\u80c3\u304c\u3093\u3001\u80ba\u304c\u3093\u306a\u3069\u306e\u56fa\u5f62\u304c\u3093\u306b\u304a\u3051\u308bADC\u306e\u6709\u52b9\u6027\u304c\u78ba\u7acb\u3055\u308c\u3064\u3064\u3042\u308a\u3001\u3053\u308c\u306b\u3088\u308a\u6cbb\u7642\u9078\u629e\u80a2\u304c\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3057\u304b\u3057\u3001ADC\u306e\u9ad8\u30b3\u30b9\u30c8\u3001\u8907\u96d1\u306a\u88fd\u9020\u30d7\u30ed\u30bb\u30b9\u3001\u304a\u3088\u3073\u6f5c\u5728\u7684\u306a\u526f\u4f5c\u7528\u306f\u3001\u5e02\u5834\u6210\u9577\u306e\u8ab2\u984c\u3068\u306a\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u8ab2\u984c\u306b\u5bfe\u51e6\u3059\u308b\u305f\u3081\u3001\u4f01\u696d\u306f\u3088\u308a\u52b9\u7387\u7684\u306a\u88fd\u9020\u65b9\u6cd5\u306e\u958b\u767a\u3084\u3001\u526f\u4f5c\u7528\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u6539\u5584\u3059\u308b\u305f\u3081\u306e\u7814\u7a76\u306b\u6ce8\u529b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3<\/p>\n<p>ADC\u5e02\u5834\u306f\u3001\u6a19\u7684\u6297\u539f\u3001\u30da\u30a4\u30ed\u30fc\u30c9\u3001\u9069\u5fdc\u75c7\u3001\u304a\u3088\u3073\u5730\u57df\u306b\u57fa\u3065\u3044\u3066\u30bb\u30b0\u30e1\u30f3\u30c8\u5316\u3067\u304d\u307e\u3059\u3002<\/p>\n<p>\u6a19\u7684\u6297\u539f\u5225\uff1a<br \/>\n* HER2<br \/>\n* CD30<br \/>\n* CD22<br \/>\n* Nectin-4<br \/>\n* \u305d\u306e\u4ed6\u306e\u6a19\u7684\u6297\u539f<\/p>\n<p>\u30da\u30a4\u30ed\u30fc\u30c9\u5225\uff1a<br \/>\n* \u30de\u30a4\u30af\u30ed\u30c1\u30e5\u30fc\u30d6\u30ea\u30f3\u963b\u5bb3\u5264<br \/>\n* DNA\u640d\u50b7\u5264<br \/>\n* \u305d\u306e\u4ed6\u306e\u30da\u30a4\u30ed\u30fc\u30c9<\/p>\n<p>\u9069\u5fdc\u75c7\u5225\uff1a<br \/>\n* \u4e73\u304c\u3093<br \/>\n* \u80c3\u304c\u3093<br \/>\n* \u80ba\u304c\u3093<br \/>\n* \u8840\u6db2\u304c\u3093<br \/>\n* \u305d\u306e\u4ed6\u306e\u56fa\u5f62\u304c\u3093<\/p>\n<p>\u5730\u57df\u5225\uff1a<br \/>\n* \u5317\u7c73<br \/>\n* \u30e8\u30fc\u30ed\u30c3\u30d1<br \/>\n* \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df<br \/>\n* \u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab<br \/>\n* \u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab<\/p>\n<p>\u4e3b\u8981\u4f01\u696d<\/p>\n<p>ADC\u5e02\u5834\u306e\u4e3b\u8981\u30d7\u30ec\u30fc\u30e4\u30fc\u306b\u306f\u3001Seagen Inc. (Pfizer Inc.\u306e\u4e00\u90e8\u9580)\u3001\u7b2c\u4e00\u4e09\u5171\u682a\u5f0f\u4f1a\u793e\u3001\u30ed\u30b7\u30e5\u30fb\u30db\u30fc\u30eb\u30c7\u30a3\u30f3\u30b0AG\u3001\u30a2\u30b9\u30c8\u30e9\u30bc\u30cd\u30abPLC\u3001\u30ae\u30ea\u30a2\u30c9\u30fb\u30b5\u30a4\u30a8\u30f3\u30b7\u30ba\u793e\u306a\u3069\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u4f01\u696d\u306f\u3001\u65b0\u88fd\u54c1\u306e\u958b\u767a\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u5b9f\u65bd\u3001\u304a\u3088\u3073\u6226\u7565\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3092\u901a\u3058\u3066\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u62e1\u5927\u3057\u3088\u3046\u3068\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u7d50\u8ad6<\/p>\n<p>ADC\u5e02\u5834\u306f\u3001\u304c\u3093\u6cbb\u7642\u306e\u30d1\u30e9\u30c0\u30a4\u30e0\u30b7\u30d5\u30c8\u3092\u8c61\u5fb4\u3059\u308b\u3082\u306e\u3067\u3042\u308a\u3001\u4eca\u5f8c\u3082\u6025\u901f\u306a\u6210\u9577\u304c\u671f\u5f85\u3055\u308c\u307e\u3059\u3002\u7cbe\u5bc6\u533b\u7642\u3078\u306e\u79fb\u884c\u3001\u6295\u8cc7\u306e\u5897\u52a0\u3001\u304a\u3088\u3073\u6280\u8853\u9769\u65b0\u304c\u3001\u3053\u306e\u5e02\u5834\u306e\u5c06\u6765\u3092\u5f62\u4f5c\u308b\u4e3b\u8981\u306a\u8981\u56e0\u3068\u306a\u308b\u3067\u3057\u3087\u3046\u3002<\/p>\n<p>\u3053\u306e\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u6297\u4f53\u85ac\u7269\u8907\u5408\u4f53\uff08ADC\uff09\u5e02\u5834\u306b\u95a2\u3059\u308b\u5305\u62ec\u7684\u306a\u5206\u6790\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>1. \u8abf\u67fb\u306e\u7bc4\u56f2\u3068\u5e02\u5834\u5b9a\u7fa9<br \/>\n\u672c\u8abf\u67fb\u3067\u306f\u3001\u816b\u760d\u6cbb\u7642\u7528\u306b\u627f\u8a8d\u3055\u308c\u305f\u3001\u307e\u305f\u306f\u5f8c\u671f\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306b\u3042\u308b\u3001\u7d30\u80de\u6bd2\u6027\u30da\u30a4\u30ed\u30fc\u30c9\u3068\u5171\u6709\u7d50\u5408\u3057\u305f\u30d2\u30c8\u307e\u305f\u306f\u30d2\u30c8\u5316\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53\u306e\u4e16\u754c\u7684\u306a\u58f2\u4e0a\u3092ADC\u5e02\u5834\u3068\u5b9a\u7fa9\u3057\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u898f\u6a21\u306f\u3001\u75c5\u9662\u304a\u3088\u3073\u5c02\u9580\u85ac\u5c40\u30c1\u30e3\u30cd\u30eb\u3092\u542b\u3080\u30e1\u30fc\u30ab\u30fc\u8ca9\u58f2\u4fa1\u683c\u3067\u8a55\u4fa1\u3055\u308c\u3001\u3059\u3079\u3066\u306e\u5264\u5f62\u306e\u5b8c\u6210\u533b\u85ac\u54c1\u304c\u5bfe\u8c61\u3067\u3059\u3002\u653e\u5c04\u514d\u75ab\u8907\u5408\u4f53\u3084\u5358\u72ec\u306e\u53d7\u8a17\u88fd\u9020\u53ce\u76ca\u306f\u5bfe\u8c61\u5916\u3068\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>2. \u8abf\u67fb\u65b9\u6cd5<br \/>\n\u8abf\u67fb\u306f\u3001\u4e00\u6b21\u8abf\u67fb\u3068\u4e8c\u6b21\u8abf\u67fb\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u53b3\u5bc6\u306a\u624b\u6cd5\u306b\u57fa\u3065\u3044\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u4e00\u6b21\u8abf\u67fb\u3067\u306f\u3001\u5317\u7c73\u3001\u6b27\u5dde\u3001\u9ad8\u6210\u9577\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306e\u533b\u7642\u816b\u760d\u533b\u3001\u75c5\u9662\u85ac\u5264\u5e2b\u3001CDMO\u79d1\u5b66\u8005\u3001\u533b\u7642\u653f\u7b56\u30a2\u30c9\u30d0\u30a4\u30b6\u30fc\u3078\u306e\u30a4\u30f3\u30bf\u30d3\u30e5\u30fc\u3092\u5b9f\u65bd\u3057\u3001\u6cbb\u7642\u6cd5\u306e\u666e\u53ca\u7387\u3001\u5e73\u5747\u8ca9\u58f2\u4fa1\u683c\u306e\u5909\u52d5\u3001\u4e0a\u5e02\u6642\u671f\u306a\u3069\u3092\u691c\u8a3c\u3057\u3001\u673a\u4e0a\u8abf\u67fb\u306e\u7d50\u679c\u3092\u88dc\u5b8c\u3057\u307e\u3057\u305f\u3002<br \/>\n*   \u4e8c\u6b21\u8abf\u67fb\u3067\u306f\u3001\u7c73\u56fdFDA\u306e\u533b\u85ac\u54c1\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u3001EMA\u306e\u30b3\u30df\u30e5\u30cb\u30c6\u30a3\u767b\u9332\u3001WHO GLOBOCAN\u306e\u304c\u3093\u767a\u751f\u7387\u30d5\u30a1\u30a4\u30eb\u3001UN Comtrade\u306e\u51fa\u8377\u30b3\u30fc\u30c9\u3001Questel\u306e\u7279\u8a31\u30d5\u30a1\u30df\u30ea\u30fc\u306a\u3069\u306e\u516c\u958b\u30c7\u30fc\u30bf\u30bb\u30c3\u30c8\u3092\u5206\u6790\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u3001\u7c73\u56fd\u304c\u3093\u5354\u4f1a\u306e\u30d5\u30a1\u30af\u30c8\u30b7\u30fc\u30c8\u3001ClinicalTrials.gov\u306e\u81e8\u5e8a\u8a66\u9a13\u30ed\u30b0\u3001Dow Jones Factiva\u3092\u901a\u3058\u3066\u30a2\u30af\u30bb\u30b9\u3057\u305f\u4f01\u696d\u5831\u544a\u66f8\uff0810-K\uff09\u3001D&#038;B Hoovers\u306e\u904e\u53bb\u306e\u58f2\u4e0a\u30c7\u30fc\u30bf\u3001BIO\u3084\u65e5\u672c\u306ePMDA\u306a\u3069\u306e\u5354\u4f1a\u30dd\u30fc\u30bf\u30eb\u304b\u3089\u696d\u754c\u306e\u80cc\u666f\u60c5\u5831\u3092\u53ce\u96c6\u3057\u307e\u3057\u305f\u3002<br \/>\n*   \u5e02\u5834\u898f\u6a21\u7b97\u51fa\u3068\u4e88\u6e2c\u306f\u3001\u30c8\u30c3\u30d7\u30c0\u30a6\u30f3\u306e\u767a\u751f\u7387\u304b\u3089\u6cbb\u7642\u3078\u306e\u518d\u69cb\u7bc9\u30e2\u30c7\u30eb\u3092\u57fa\u76e4\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u56fd\u30ec\u30d9\u30eb\u306e\u304c\u3093\u75c7\u4f8b\u6570\u304b\u3089\u6709\u75c5\u7387\u30b3\u30db\u30fc\u30c8\u3092\u7b97\u51fa\u3057\u3001ADC\u666e\u53ca\u7387\u3068\u5e73\u5747\u6cbb\u7642\u8cbb\u7528\u3092\u4e57\u3058\u3066\u3044\u307e\u3059\u3002\u30dc\u30c8\u30e0\u30a2\u30c3\u30d7\u30c1\u30a7\u30c3\u30af\u3001\u30e1\u30fc\u30ab\u30fc\u53ce\u76ca\u306e\u96c6\u8a08\u3001\u5165\u672d\u30c7\u30fc\u30bf\u306e\u30b5\u30f3\u30d7\u30ea\u30f3\u30b0\u3001\u7a3c\u50cd\u7387\u306e\u30b9\u30ca\u30c3\u30d7\u30b7\u30e7\u30c3\u30c8\u306b\u3088\u308a\u3001\u7dcf\u8a08\u3092\u8abf\u6574\u3057\u307e\u3057\u305f\u3002ADC\u627f\u8a8d\u6570\u30013\u5e74\u76ee\u4ee5\u964d\u306e\u4fa1\u683c\u6d78\u98df\u3001\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306e\u8131\u843d\u7387\u3001\u5730\u57df\u3054\u3068\u306e\u511f\u9084\u7bc4\u56f2\u3001\u5207\u65ad\u53ef\u80fd\u30ea\u30f3\u30ab\u30fc\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u306a\u3069\u306e\u4e3b\u8981\u5909\u6570\u3092\u8003\u616e\u3057\u3001\u591a\u5909\u91cf\u56de\u5e30\u5206\u6790\u3092\u7528\u3044\u30662030\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u30c7\u30fc\u30bf\u691c\u8a3c\u3068\u66f4\u65b0\u306f\u3001\u72ec\u7acb\u3057\u305f\u6297\u304c\u3093\u5264\u6307\u6a19\u3001\u7af6\u5408\u30c7\u30fc\u30bf\u3001\u904e\u53bb\u306e\u30ec\u30dd\u30fc\u30c8\u7248\u3068\u306e\u5dee\u7570\u3092\u691c\u8a3c\u3057\u3001\u7570\u5e38\u5024\u306f\u4fee\u6b63\u3055\u308c\u307e\u3059\u3002\u30ec\u30dd\u30fc\u30c8\u306f\u6bce\u5e74\u66f4\u65b0\u3055\u308c\u3001\u91cd\u8981\u306a\u30a4\u30d9\u30f3\u30c8\u3001\u4e3b\u8981\u306a\u627f\u8a8d\u3001\u307e\u305f\u306f\u5b89\u5168\u6027\u306b\u95a2\u3059\u308b\u64a4\u56de\u304c\u3042\u3063\u305f\u5834\u5408\u306b\u306f\u4e2d\u9593\u4fee\u6b63\u304c\u884c\u308f\u308c\u307e\u3059\u3002<\/p>\n<p>3. \u5e02\u5834\u306e\u6982\u8981<br \/>\n*   \u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0\u3068\u3057\u3066\u306f\u3001\u56fa\u5f62\u816b\u760d\u306e\u767a\u751f\u7387\u5897\u52a0\u300165\u6b73\u4ee5\u4e0a\u306e\u4eba\u53e3\u306e\u6025\u901f\u306a\u62e1\u5927\u3001R&#038;D\u8cc7\u91d1\u3068\u81e8\u5e8a\u8a66\u9a13\u958b\u59cb\u306e\u52a0\u901f\u3001\u88fd\u85ac\u6295\u8cc7\u306e\u5897\u52a0\u3001\u4f4e\u6bd2\u6027\u3067\u52b9\u679c\u7684\u306a\u85ac\u5264\u3078\u306e\u9700\u8981\u306e\u9ad8\u307e\u308a\u3001\u305d\u3057\u3066\u65e5\u672c\u3068\u30c9\u30a4\u30c4\u306b\u304a\u3051\u308b\u5916\u6765ADC\u6295\u4e0e\u306e\u511f\u9084\u62e1\u5927\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002<br \/>\n*   \u5e02\u5834\u306e\u963b\u5bb3\u8981\u56e0\u306b\u306f\u3001\u9ad8\u984d\u306a\u6cbb\u7642\u8cbb\u3001\u30da\u30a4\u30ed\u30fc\u30c9\uff08\u30aa\u30fc\u30ea\u30b9\u30bf\u30c1\u30f3\/PBD\uff09\u4f9b\u7d66\u306e\u5236\u7d04\u306b\u3088\u308b\u751f\u7523\u30dc\u30c8\u30eb\u30cd\u30c3\u30af\u3001\u65b0\u8208\u306eT\u7d30\u80de\u30a8\u30f3\u30b2\u30fc\u30b8\u30e3\u30fc\u3084\u4e8c\u91cd\u7279\u7570\u6027\u6297\u4f53\u3068\u306e\u7af6\u5408\u3001\u88fd\u9020\u306e\u8907\u96d1\u6027\u304c\u8ab2\u984c\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u305d\u306e\u4ed6\u3001\u30d0\u30ea\u30e5\u30fc\u30c1\u30a7\u30fc\u30f3\u5206\u6790\u3001\u898f\u5236\u52d5\u5411\u3001\u6280\u8853\u52d5\u5411\u3001\u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790\uff08\u8cb7\u3044\u624b\u306e\u4ea4\u6e09\u529b\u3001\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u306e\u4ea4\u6e09\u529b\u3001\u65b0\u898f\u53c2\u5165\u306e\u8105\u5a01\u3001\u4ee3\u66ff\u54c1\u306e\u8105\u5a01\u3001\u7af6\u4e89\u306e\u6fc0\u3057\u3055\uff09\u306b\u3064\u3044\u3066\u3082\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>4. \u5e02\u5834\u898f\u6a21\u3068\u6210\u9577\u4e88\u6e2c\uff08USD\u30d9\u30fc\u30b9\uff09<br \/>\n\u5e02\u5834\u306f\u4ee5\u4e0b\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u5206\u985e\u3055\u308c\u3001\u305d\u308c\u305e\u308c\u306b\u3064\u3044\u3066\u898f\u6a21\u3068\u6210\u9577\u304c\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u88fd\u54c1\u5225: Adcetris (brentuximab vedotin)\u3001Kadcyla (trastuzumab emtansine)\u3001Padcev (enfortumab vedotin)\u3001Polivy (polatuzumab vedotin)\u3001Enhertu (trastuzumab deruxtecan)\u3001Trodelvy (sacituzumab govitecan)\u3001Elahere (mirvetuximab soravtansine)\u3001\u305d\u306e\u4ed6\u306e\u627f\u8a8d\u6e08\u307fADC\u3002<br \/>\n*   \u30ea\u30f3\u30ab\u30fc\u5316\u5b66\u5225: \u5207\u65ad\u53ef\u80fd\u30ea\u30f3\u30ab\u30fc\u3001\u975e\u5207\u65ad\u53ef\u80fd\u30ea\u30f3\u30ab\u30fc\u3001\u90e8\u4f4d\u7279\u7570\u7684\/\u6b21\u4e16\u4ee3\u7d50\u5408\u6280\u8853\u3002<br \/>\n*   \u6a19\u7684\u6297\u539f\u5225: HER2\u3001CD30\u3001TROP2\u3001CD22\u3001\u305d\u306e\u4ed6\u3002<br \/>\n*   \u7528\u9014\uff08\u9069\u5fdc\u75c7\uff09\u5225: \u4e73\u304c\u3093\u3001\u8840\u6db2\u304c\u3093\uff08\u30ea\u30f3\u30d1\u816b\u3001\u767d\u8840\u75c5\uff09\u3001\u5c3f\u8def\u4e0a\u76ae\u304c\u3093\u3001\u80ba\u304c\u3093\u3001\u5a66\u4eba\u79d1\u304c\u3093\uff08\u5375\u5de3\u304c\u3093\u3001\u5b50\u5bae\u5185\u819c\u304c\u3093\uff09\u3001\u305d\u306e\u4ed6\u306e\u56fa\u5f62\u816b\u760d\u3002<br \/>\n*   \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225: \u75c5\u9662\u3001\u5c02\u9580\u304c\u3093\u30bb\u30f3\u30bf\u30fc\u3001\u30d0\u30a4\u30aa\u30d5\u30a1\u30fc\u30de\u304a\u3088\u3073\u53d7\u8a17\u7814\u7a76\u6a5f\u95a2\uff08CRO\uff09\u3001\u305d\u306e\u4ed6\u3002<br \/>\n*   \u5730\u57df\u5225: \u5317\u7c73\uff08\u7c73\u56fd\u3001\u30ab\u30ca\u30c0\u3001\u30e1\u30ad\u30b7\u30b3\uff09\u3001\u6b27\u5dde\uff08\u30c9\u30a4\u30c4\u3001\u82f1\u56fd\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u3001\u305d\u306e\u4ed6\u6b27\u5dde\uff09\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\uff08\u4e2d\u56fd\u3001\u65e5\u672c\u3001\u30a4\u30f3\u30c9\u3001\u97d3\u56fd\u3001\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u3001\u305d\u306e\u4ed6\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\uff09\u3001\u4e2d\u6771\uff08GCC\u3001\u5357\u30a2\u30d5\u30ea\u30ab\u3001\u305d\u306e\u4ed6\u4e2d\u6771\uff09\u3001\u5357\u7c73\uff08\u30d6\u30e9\u30b8\u30eb\u3001\u30a2\u30eb\u30bc\u30f3\u30c1\u30f3\u3001\u305d\u306e\u4ed6\u5357\u7c73\uff09\u3002<\/p>\n<p>5. \u7af6\u5408\u72b6\u6cc1<br \/>\n\u5e02\u5834\u96c6\u4e2d\u5ea6\u3001\u6226\u7565\u7684\u52d5\u5411\u3001\u5e02\u5834\u30b7\u30a7\u30a2\u5206\u6790\u304c\u63d0\u4f9b\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4e3b\u8981\u4f01\u696d\u3068\u3057\u3066\u306f\u3001Pfizer Inc. (Seagen Inc.)\u3001F. Hoffmann-La Roche Ltd\u3001AstraZeneca plc\u3001AbbVie Inc.\u3001Daiichi Sankyo Co. Ltd\u3001Gilead Sciences Inc.\u3001Takeda Pharmaceutical Co. Ltd\u3001ADC Therapeutics SA\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u3001\u5404\u793e\u306e\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\uff08\u30b0\u30ed\u30fc\u30d0\u30eb\u304a\u3088\u3073\u5e02\u5834\u30ec\u30d9\u30eb\u306e\u6982\u8981\u3001\u4e3b\u8981\u30bb\u30b0\u30e1\u30f3\u30c8\u3001\u8ca1\u52d9\u60c5\u5831\u3001\u6226\u7565\u60c5\u5831\u3001\u5e02\u5834\u30e9\u30f3\u30af\/\u30b7\u30a7\u30a2\u3001\u88fd\u54c1\u3068\u30b5\u30fc\u30d3\u30b9\u3001\u6700\u8fd1\u306e\u52d5\u5411\uff09\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>6. \u5e02\u5834\u6a5f\u4f1a\u3068\u5c06\u6765\u5c55\u671b<br \/>\n\u672a\u958b\u62d3\u9818\u57df\u3068\u6e80\u305f\u3055\u308c\u3066\u3044\u306a\u3044\u30cb\u30fc\u30ba\u306e\u8a55\u4fa1\u3092\u901a\u3058\u3066\u3001\u5e02\u5834\u306e\u6a5f\u4f1a\u3068\u5c06\u6765\u306e\u5c55\u671b\u304c\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>7. \u4e3b\u8981\u306a\u8cea\u554f\u3078\u306e\u56de\u7b54<br \/>\n*   \u6297\u4f53\u85ac\u7269\u8907\u5408\u4f53\u5e02\u5834\u898f\u6a21\u306f\u30012030\u5e74\u307e\u3067\u306b570.2\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306f\u3001\u511f\u9084\u62e1\u5927\u3068\u88fd\u9020\u80fd\u529b\u306e\u5411\u4e0a\u306b\u3088\u308a\u3001\u6700\u3082\u9ad8\u3044\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff09\u3092\u793a\u3059\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   Enhertu\u306f\u3001\u4e73\u304c\u3093\u3001\u80c3\u304c\u3093\u3001\u80ba\u304c\u3093\u306b\u304a\u3051\u308b\u591a\u9069\u5fdc\u75c7\u627f\u8a8d\u306b\u3088\u308a\u3001\u73fe\u5728\u6700\u5927\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u5207\u65ad\u53ef\u80fd\u30ea\u30f3\u30ab\u30fc\u306f\u3001\u5168\u8eab\u5b89\u5b9a\u6027\u3068\u816b\u760d\u7279\u7570\u7684\u306a\u30da\u30a4\u30ed\u30fc\u30c9\u653e\u51fa\u306e\u52b9\u7387\u7684\u306a\u30d0\u30e9\u30f3\u30b9\u3092\u63d0\u4f9b\u3059\u308b\u305f\u3081\u3001\u73fe\u5728\u306eADC\u8a2d\u8a08\u3067\u512a\u4f4d\u306b\u7acb\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3053\u306e\u30ec\u30dd\u30fc\u30c8\u306f\u3001ADC\u5e02\u5834\u306e\u52d5\u5411\u3001\u6210\u9577\u8981\u56e0\u3001\u8ab2\u984c\u3001\u305d\u3057\u3066\u5c06\u6765\u306e\u6a5f\u4f1a\u3092\u6df1\u304f\u7406\u89e3\u3059\u308b\u305f\u3081\u306e\u91cd\u8981\u306a\u60c5\u5831\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/70624"}],"collection":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/comments?post=70624"}],"version-history":[{"count":0,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/70624\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/media?parent=70624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/categories?post=70624"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/tags?post=70624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}